论文部分内容阅读
对4例肝恶性肿瘤患儿(肝横纹肌肉瘤2例,肝癌2例)进行了5次介入治疗。肿瘤平均缩小3.1cm,1例做了Ⅱ期手术切除,患儿长期生存。3例症状缓解。全部病例未出现骨髓抑制及肝功能严重损害等副作用。作者认为对巨大或手术不能切除的肿瘤该方法应为首选。
Four interventional treatments were performed on four patients with liver cancer (2 with liver rhabdomyosarcoma and 2 with liver cancer). On average, tumor size was reduced by 3.1cm. One patient underwent stage Ⅱ resection and had long-term survival. 3 cases of remission. All cases did not appear bone marrow suppression and severe side effects such as liver damage. The authors believe that this method should be the first choice of the tumor can not be huge or surgery.